These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3126841)

  • 1. Biodegradable hollow fibres for the controlled release of drugs.
    Schakenraad JM; Oosterbaan JA; Nieuwenhuis P; Molenaar I; Olijslager J; Potman W; Eenink MJ; Feijen J
    Biomaterials; 1988 Jan; 9(1):116-20. PubMed ID: 3126841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled drug release from poly(ortho esters).
    Heller J
    Ann N Y Acad Sci; 1985; 446():51-66. PubMed ID: 3925854
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term controlled delivery of levonorgestrel in rats by means of small biodegradable cylinders.
    Wise DL; Rosenkrantz H; Gregory JB; Esber HJ
    J Pharm Pharmacol; 1980 Jun; 32(6):399-403. PubMed ID: 6106671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation of biodegradable films containing the potent osteogenic compound BFB0261 for localized delivery.
    Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S
    Int J Pharm; 2011 Feb; 404(1-2):10-8. PubMed ID: 21047548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(ortho ester) biodegradable polymer systems.
    Heller J; Himmelstein KJ
    Methods Enzymol; 1985; 112():422-36. PubMed ID: 3930918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravitreal drug delivery by microspheres of biodegradable polymers].
    Moritera T; Ogura Y; Honda Y; Wada R; Hyon SH; Ikada Y
    Nippon Ganka Gakkai Zasshi; 1990 May; 94(5):508-13. PubMed ID: 2220493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo degradation and biocompatibility study of in vitro pre-degraded as-polymerized polyactide particles.
    Bergsma JE; Rozema FR; Bos RR; Boering G; de Bruijn WC; Pennings AJ
    Biomaterials; 1995 Mar; 16(4):267-74. PubMed ID: 7772665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable poly(DL-lactic acid) formulations in a calcitonin delivery system.
    Asano M; Yoshida M; Omichi H; Mashimo T; Okabe K; Yuasa H; Yamanaka H; Morimoto S; Sakakibara H
    Biomaterials; 1993 Aug; 14(10):797-9. PubMed ID: 8218732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo characteristics of low molecular weight copoly (D,L-lactic acid) formulations with controlled release of LH-RH agonist.
    Asano M; Fukuzaki H; Yoshida M; Kumakura M; Mashimo T; Yuasa H; Imai K; Yamanaka H
    Biomaterials; 1989 Oct; 10(8):569-73. PubMed ID: 2513891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biological basis for poly-L-lactic acid-induced augmentation.
    Stein P; Vitavska O; Kind P; Hoppe W; Wieczorek H; Schürer NY
    J Dermatol Sci; 2015 Apr; 78(1):26-33. PubMed ID: 25703057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanical properties of biodegradable ligament augmentation device of poly(L-lactide) in vitro and in vivo.
    Laitinen O; Törmälä P; Taurio R; Skutnabb K; Saarelainen K; Iivonen T; Vainionpää S
    Biomaterials; 1992; 13(14):1012-6. PubMed ID: 1472587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced biocompatibility and wound healing properties of biodegradable polymer-modified allyl 2-cyanoacrylate tissue adhesive.
    Lee YJ; Son HS; Jung GB; Kim JH; Choi S; Lee GJ; Park HK
    Mater Sci Eng C Mater Biol Appl; 2015 Jun; 51():43-50. PubMed ID: 25842106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable biodegradable polymeric device in the treatment of experimental proliferative vitreoretinopathy.
    Hashizoe M; Ogura Y; Takanashi T; Kunou N; Honda Y; Ikada Y
    Curr Eye Res; 1995 Jun; 14(6):473-7. PubMed ID: 7671629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new vitreal drug delivery system using an implantable biodegradable polymeric device.
    Kimura H; Ogura Y; Hashizoe M; Nishiwaki H; Honda Y; Ikada Y
    Invest Ophthalmol Vis Sci; 1994 May; 35(6):2815-9. PubMed ID: 8188476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of and tissue reaction to biodegradable poly(L-lactide) for use as internal fixation of fractures: a study in rats.
    Bos RR; Rozema FR; Boering G; Nijenhuis AJ; Pennings AJ; Verwey AB; Nieuwenhuis P; Jansen HW
    Biomaterials; 1991 Jan; 12(1):32-6. PubMed ID: 2009343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preparation of ibuprofen/sPEG-b-PLLA copolymer microspheres and its in vitro release properties].
    Lin YL; Zhang AQ; Guan FY; Chen YD; Tan WA; Wang LS
    Yao Xue Xue Bao; 2010 Dec; 45(12):1570-5. PubMed ID: 21351499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic activity toward poly(L-lactic acid) implants.
    Schakenraad JM; Hardonk MJ; Feijen J; Molenaar I; Nieuwenhuis P
    J Biomed Mater Res; 1990 May; 24(5):529-45. PubMed ID: 2324125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a biodegradable contraceptive capsule (Capronor) containing levonorgestrel on gonadotropin, estrogen, and progesterone levels.
    Ory SJ; Hammond CB; Yancy SG; Hendren RW; Pitt CG
    Am J Obstet Gynecol; 1983 Mar; 145(5):600-5. PubMed ID: 6402933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers.
    Freed LE; Marquis JC; Nohria A; Emmanual J; Mikos AG; Langer R
    J Biomed Mater Res; 1993 Jan; 27(1):11-23. PubMed ID: 8380593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of in vitro drug release, pH change, and molecular weight degradation of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) fibers.
    Crow BB; Borneman AF; Hawkins DL; Smith GM; Nelson KD
    Tissue Eng; 2005; 11(7-8):1077-84. PubMed ID: 16144443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.